ConductScience.org, home

Paper34792

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Weiden PL and 6 others. N Engl J Med, 1979. Cited by 1,373 papers, by iCite.

Cite this record

ConductScience Library. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. Papers, record 34792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
PubMed
Journal
N Engl J Med
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,373
iCite
Relative citation ratio, by iCite
27.9
iCite
Revised in PubMed
2021-01-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weiden PLP L
2Flournoy NN
3Thomas EDE D
4Prentice RR
5Fefer AA
6Buckner CDC D
7Storb RR

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
Graft vs Host ReactionMajor topic
LeukemiaMajor topic
Acute Disease
Female
HLA Antigens
Humans
Leukemia, Lymphoid
Pregnancy
Probability
Prognosis
Recurrence
Remission, Spontaneous
Transplantation, Homologous
Transplantation, Isogeneic
Twins

Source PubMed

Download CSV of topics

Cited by375

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,373 citations.

PMIDTitleJournalYearIn PapersSource
42957220Suspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution.In Vivo2026https://conductscience.org/library/papers/42957220PubMed
42955162The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies.Curr Hematol Malig Rep2026https://conductscience.org/library/papers/42955162PubMed
42794950Targeting the Epigenetic-Immune Axes in Hematologic Malignancies.Cancers (Basel)2026https://conductscience.org/library/papers/42794950PubMed
42617044CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GVL while limiting GVHD after HSCT.Blood Adv2026https://conductscience.org/library/papers/42617044PubMed
42519395Pediatric AML CAR T cell therapy.Mol Ther Oncol2026https://conductscience.org/library/papers/42519395PubMed
42480219Long-acting pegylated interferon gamma sensitizes AML cells to killing by donor T cells.Blood Adv2026https://conductscience.org/library/papers/42480219PubMed
41857187
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry.
Bone Marrow Transplant2026https://conductscience.org/library/papers/41857187PubMed
41761243Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer.Cell Commun Signal2026https://conductscience.org/library/papers/41761243PubMed
41566777Strategies to eliminate native T cell receptors for adoptive T cell therapies.Mol Ther2026https://conductscience.org/library/papers/41566777PubMed
41394288CAR T-cell therapy for neurological disorders: scientific rationale and mechanistic insights.Ther Adv Neurol Disord2025https://conductscience.org/library/papers/41394288PubMed
41347998Gene transfer and genome editing of T cells for cancer immunotherapy: from allogeneic HSCT to TCR gene editing.Hematology Am Soc Hematol Educ Program2025https://conductscience.org/library/papers/41347998PubMed
41091527Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy.Clin Transplant2025https://conductscience.org/library/papers/41091527PubMed
40864984CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia.Blood2025https://conductscience.org/library/papers/40864984PubMed
40841587Targeting the roots of myeloid malignancies with T cell receptors.Nat Rev Cancer2025https://conductscience.org/library/papers/40841587PubMed
40810334
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation.
Br J Haematol2025https://conductscience.org/library/papers/40810334PubMed
40488825Optimal GVHD Prophylaxis.Adv Exp Med Biol2025https://conductscience.org/library/papers/40488825PubMed
40458939Graft-versus-leukemia.Haematologica2025https://conductscience.org/library/papers/40458939PubMed
40429375Hematopoietic Stem Cell Transplantation: Recent Advances.J Clin Med2025https://conductscience.org/library/papers/40429375PubMed
40207714Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation.Haematologica2025https://conductscience.org/library/papers/40207714PubMed
39766080Antibody-Based Immunotherapies for the Treatment of Hematologic Malignancies.Cancers (Basel)2024https://conductscience.org/library/papers/39766080PubMed

See all 375 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34792

GET https://conductscience.org/api/papers/v1/34792/cited_by?page=2